Cognitive Behavioural Therapy for Vestibular Migraine

Not Applicable

Completed

• Conditions: Vestibular migraine; Depression; Anxiety; Neurological - Other neurological disorders; Mental Health - Depression; Mental Health - Anxiety

• Registration Number: ACTRN12611001086954
• Lead Sponsor: Royal Prince Alfred Hospital

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2011-10-19
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 70

Inclusion Criteria

People with vestibular migraine

Exclusion Criteria

About to undergo major surgery or significant change to medication
Significantly impaired cognitive functioning
Psychosis
Inability to speak English

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Migraine frequency. This will be measured using participant self-report diaries and the Migraine Disability Assessment Questionnaire (MIDAS; Lipton et al., 2001) 7-item scale strongly related to migraine frequency.[Diary kept one week prior to commencement of the groups and throughout treatment. MIDAS administered pre-treatment (assessment session) at post-treatment (final therapy session) then 3 and 6 months post-treatment.];Dizziness handicap. This will be measured using the Dizziness Handicap Inventory (DHI; Jacobsen & Newman, 1990) 25-item scale to measure self-perceived handicap experienced due to vestibular system disease.[Pre-treatment (assessment session) at post-treatment (final therapy session) then 3 and 6 months post-treatment.];Anxiety and depression symptomatology. This will be measured using the Hospital Anxiety Depression Scale (HADS; Zigmond & Snaith, 1983) 14 item self-report measure.[Pre-treatment, post-treatment, three and six month follow-up]

Secondary Outcome Measures

Name	Time	Method
Quality of life. This will be measured using the WHOQoL-BREF Australian version (WHO, 2000) 26 item self-report measure.[Pre-treatment (assessment session) at post-treatment (post final therapy session) and then 3 and 6 months post-treatment.]